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ABSTRACT 
Bangladesh is a rustic of rising economy. The causes of its rising is high rate of industrialization 
and investment in different sectors. The pharmaceutical sector that is the second largest export earning 
source of the country after Ready Made Garments contributes almost 1% of the GDP and is currently the 
third largest tax paying sector in the country. Square Pharmaceutical Limited (SPL) the biggest name in 
the pharmaceutical sector of Bangladesh has a market share of 19.3% and the total exporting amount 
become BDT 1,137.99 millions in FY 2016-2017 that is 34.46% more than the previous year. This paper is 
almost done using the secondary data though a slight primary data is used where customer’s choice is 
examined where the highest 38% of the customer like the brand name square. This study assessed and 
examined the role of pharmaceutical company to the economy of Bangladesh from the perspective of 
square pharmaceutical limited as the sample company. The researcher also investigates the corporate 
social responsibility activities played by the respective company. This paper will be useful to the 
pharmaceutical companies, concerned authorities, policy makers and the government to know the role 
of pharmaceutical sector and required initiatives to eliminate all the hindrances and resolve all the 
problems to make out pharmaceutical sector as a crucial actor in both domestic and international market. 
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INTRODUCTION 
The economy of Bangladesh is moving forward every day 
at the back of our industries. It has constructed a solid base 
of the pharmaceutical area that is the second one biggest 
export incomes source of country after Ready Made 
garments and this strong base is taken into consideration 
to come to be a capability sector in the approaching days 
to aid our economy. Prior to the Liberation battle of 1971 
there has been in frequently any pharmaceutical 
enterprise in Bangladesh, even after the liberation struggle 
the new government could not allot sufficient price range 
for fitness sector. After the annunciation of Drug 
manipulates Ordinance -1982, the pharmaceutical sector 
began to enlarge vertically.  
In keeping with the Directorate preferred of Drug 
management (DGDA), the marketplace percentage of the 
domestically produced drug changed into175 crore in 1981 
that improved to 325 crore with the aid of 1985. Many years 
after its emergence Bangladesh is now placed to end up a 
main exporter of pharmaceutical products. Skillful 
attitudes, expertise and progressive thoughts from the 
specialists have been the key reasons why this enterprise 
grew within the manner it did. After Nineteen Nineties, 
some of the agencies started producing insulin, hormones 
and cancer preventing pills the ones were now not formerly 
produced in the country. The modern-day nearby 
pharmaceutical market length of Bangladesh is expected to 
be approximate Tk. 1.3 Billion USD and the yearly growth 
price emerge as 11.36% that became about 8.12 % in 2013. 
The Pharmaceutical industry of Bangladesh is now self-
contained in pleasurable the local. The yearly average boom 
price of prescribed drugs has hit double digit considering 
2009. Pharmaceutical groups satisfy greater than ninety 7% 
of nearby call for of medicines and about 30 companies 
export a good sized  amount of drugs to 107 countries, 
along with Germany, USA, France, Italy, united kingdom, 
Canada, Netherlands and Denmark. There are 
approximately 250 organizations energetic in the 
marketplace for the time being. This rapidly developing 
enterprise contributes nearly 1% of the GDP and is 
presently the third biggest tax paying region within the 
USA. Its Tk. four billion ($51.7m) in pharmaceutical export 
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profits pales in comparison to the $20 billion the country 
makes from readymade garment exports. However the 
region’s increase is outstanding given the reality those two 
decades in the past, seventy five% of Bangladesh's 
pharmaceutical merchandise had been imported. In 
keeping with international marketing offerings (IMS), 
Bangladesh's home pharmaceuticals market grew nearly 
thirteen% to $250m in 2013. Pharmaceutical exports from 
Bangladesh rose 15.sixty five percent year-on-yr to Tk 553.3 
crore in monetary 2016-17, riding on the returned of 
developing international demand, high great products and 
competitive fees. There are about 450 generics registered in 
Bangladesh. Out of those 450 generics, 117 are within the 
controlled category i.e. within the critical drug list. The last 
333 generics are in the decontrolled category; the total wide 
variety of manufacturers or gadgets which are registered in 
Bangladesh is presently envisioned to be 537 even as the full 
quantity of dosage bureaucracy and strengths are 830. 
Bangladesh pharmaceutical industry is specially ruled by 
means of home manufacturers. Of the total pharmaceutical 
marketplace of Bangladesh, the local businesses are taking 
part in a market proportion accomplish in around 80%, 
even as the MNCs are having a marketplace percentage of 
20%. Out of the top ten pharmaceutical agencies in 
Bangladesh, 8 are nearby pharmaceutical groups; at the 
same time as most effective are MNCs. The pharmaceutical 
quarter has already been declared as the thrust zone by 
means of the government of Bangladesh. 
The leading pharmaceutical organizations in Bangladesh 
are rectangular prescription drugs, Beximco Pharma, 
Incepta Pharma, Opsonin Pharma and ESkayef 
Bangladesh. Square and Beximco have a blended market 
proportion of 20%. The corporations in most cases 
produce capsules against AIDS, diabetes, bronchial 
asthma, cancer and various different sicknesses. The most 
important call within the pharmaceutical area of 
Bangladesh is square prescription drugs constrained 
(SPL). It has a market percentage of 93%. Incepta 
Pharmaceutical and Beximco prescribed drugs 
respectively have 8.5% and 7.6% market share. Its journey 
to the increase and prosperity has been no bed of roses. 
From the inception in 1958, it has nowadays burgeoned 
into one of the top line conglomerates in Bangladesh. 
Square prescription drugs Ltd., the flagship corporation, 
is maintaining the strong leadership role in the 
pharmaceutical industry of Bangladesh due to the fact that 
1985 and is now on its manner to becoming a excessive 
overall performance international participant. 
The marketplace length, marketplace share and boom of 
rectangular pharmaceuticals Ltd are BDT 19,722,066,693, 
19.4% and 25.36% respectively where the second one 
function maintaining employer call Incepta Pharma in the 
country display the consequences of marketplace size, 
market share and boom are BDT 10,184,993,624, 10.02% and 
11.84% respectively. The Chemical department of square 
started business production in 1995. From the year 1997 it 
started out its complete-fledged production and advertising 
to all top prescribed drugs within the country together with 
Aventis Pharma, Novartis Bangladesh Ltd., Glaxo Smith 
Kline, ACI Ltd., Reckitt & Colman, Beximco prescription 
drugs Ltd., The ACME Laboratories Ltd, Eskayf Bangladesh 
Ltd., Opsonin chemicals, Renata Ltd., important pills Co. 
Ltd. and so on with accurate reputation and loyalty. Square 
commenced exporting finished pharmaceutical formulations 
considering the fact that 1987. Square gives more than 200 
molecules in over 350 formulations, from its 2 WHO GMP-
compliant production plant life. As popularity to its export 
contribution to countrywide financial system, square 
received the country wide Export Trophy in 1997. To bolster 
its international operation in addition, rectangular is 
planning to go into in Russian Pharma marketplace thinking 
about market potentiality. To preserve the changing 
environment SPL made convert itself into Public constrained 
enterprise in 1991.  
With an incredible music document SPL became the first 
enterprise in Bangladesh to move the Billion Taka mark 
turnover in 1992. In 1994 SPL got its share listed within the 
Dhaka and Chittagong inventory Exchanges. Authorized 
Capital towered to billion taka and paid up capital 
through now could be taka 250 million. Currently square 
is circle of relatives of 1321 participants. It has scaled-up 
CSR sports to do not forget the hobbies of our external & 
internal stakeholders like customers, personnel, 
providers, shareholders, society, government and many 
others and ecological & ethical considerations in all factors 
of operations. Square herbal & Nutraceuticals Ltd. 
(SHNL) has been presented the “Asia responsible 
Entrepreneurship Awards 2014-South Asia” beneath the 
class of ‘Social Empowerment Award’. The Asia 
responsible Entrepreneurship Awards is a nearby 
reputation Award organized by using business enterprise 
Asia to honor groups for super, innovative and global 
elegance products, offerings, projects and applications. 
Those packages reveal the organization’s management, 
sincerity and on-going commitment in incorporating 
responsible and ethical values, criminal compliance, 
issues for fitness issues, respect for humans and people, 
involvement in groups and protection of the surroundings 
into the way they run their employer. The take a look at 
tries to cope with function of square pharmaceutical 
restricted from the monetary and social duty viewpoints 
that contributing the country in view that long term. 
LITERATURE REVIEW 
Review of literature is an integral part of conducting a 
research. This is necessary to find out the research gap in 
the proposed field of the study. The researcher has 
reviewed some related literatures in order to find out 
research gap regarding the role of square pharmaceutical 
limited in Bangladesh. It clarifies that different authors 
have conducted research on different topics, but not a 
single research has been conducted on the present titled of 
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this study. In this study the researcher readout some 
books, journals, newspapers and published papers which 
are very much helpful to identify the overall role of 
pharmaceutical industries to the economy of Bangladesh 
particularly the role of Square Pharmaceutical Limited.  
Anesary et al. (2014) opined that the pharmaceutical 
enterprise in Bangladesh is one of the most advanced hi-
tech sectors in   Bangladesh Economy. Bangladesh 
pharmaceutical industry is specially ruled through 
domestic manufacturers. Particularly Square 
pharmaceuticals retained the pinnacle role with its local 
income achieving Tk 19.72 billion in 2017 inside the 
country’s Tk 101 billion pharmaceutical market followed 
by Incepta Pharmaceuticals company. Ishika (2010) 
highlighted that Squarer Pharmaceuticals Limited (SPL) is 
the biggest pharmaceutical organization in Bangladesh 
and it has been continuously in the1st place amongst all 
countrywide and multinational agencies seeing 
that1985.It was established in 1958 and being transformed 
into a public limited corporation in 1991. Akter (2015) 
mentioned that the financial system of Bangladesh is 
shifting ahead each day on the returned of our industries. 
Apart from the fabric and garments industry that 
accommodates maximum of the employment and export 
proportion, there are other industries which might be 
supporting the financial system and providing a balance 
via import substitution. These industries have great 
capability to flourish and as a country is inching in the 
direction of a middle-income popularity, they have got 
loads to provide to the financial system. Mazumder (2015) 
point out that during the mid-1970s (1975) SPL entered into 
a technical collaboration agreement with Janssen 
pharmaceuticals, Belgium, which is a subsidiary of Johnson 
and Johnson international, USA. Since that its inception SPL 
practices accurate manufacturing Practices (GMP), as 
endorsed via the arena health agency (WHO), SPL’s growth 
was now not being stunted. In 1982, turnover reached over 
Tk. 240 million, and the payroll extended 400 heads, and 
with the aid of 1988 SPL’s turnover exceeded 1/2 a billion 
taka., and the range of employees to 750. At gift SPL is 
exporting its products to Nepal, Myanmar, Pakistan, Sri-
Lanka, Cambodia, and Russia. 
RATIONALE OF THE STUDY 
The pharmaceutical sector has emerged as one of the fastest 
growing business sector in present Bangladesh. It is the 
second highest contributors to our national exchequer, and it 
is the largest white collar labor intensive employment sector. 
The present study is aimed at role of square pharmaceutical 
limited in Bangladesh. It is done on the basis of self-effort and 
the data collected from different sources. Obviously this 
study will enhance the level of knowing of us about the 
economic and social responsibilities played by square 
pharmaceutical limited and will help us to apply the 
knowledge in other sectors. It will also help to develop the 
efficiency of the concerned authority and the policy makers 
of the pharmaceutical sectors. 
OBJECTIVE OF THE STUDY 
The main objective of this study is to review the role of 
square pharmaceutical limited to the economy and society 
of Bangladesh. The study is also designed to achieve the 
following objectives: 
 To assess the comparative financial performance of 
square pharmaceutical limited over the study period. 
 To investigate the contribution of pharmaceutical 
companies to the national economy of Bangladesh. 
 To make the recommendations for the sound role 
management in future of the pharmaceutical 
industries in Bangladesh.     
MATERIALS AND METHODS 
The study is quantitative in nature. The present study is 
conducted mainly on the basis of secondary data and it is 
concerned with pharmaceutical sector of Bangladesh. To 
conduct this study the researcher has taken square 
pharmaceutical limited as the sample company from 
pharmaceutical sectors of Bangladesh. This research also 
conducted a small survey over the customer of 
pharmaceutical product and their choices. The sample was 
taken from different hospitals and pharmacy that came to 
buy the products. On the basis of availability of data, 
accuracy of data, time span and cost factor of the study, 
secondary data play a significant role in research (Sekaran, 
U., 2002). Data has been collected from the published 
research papers, different books, dissertations, assignment 
or internship reports, annual reports of the company and 
newspapers concerning the study. The data has been 
analyzed on the first hand collection presented and 
analyzed through simple statistical tools such as charts, 
tables, percentages which show the corresponding years.  
LIMITATION OF THE STUDY 
The limitation of this study is that this study did not use 
optimum primary data rather a slight respondent are 
interviewed from different hospitals and pharmacy only to 
investigate the percentage of choice of buying the product of 
respective company. This study did not use the modern 
statistical tools to analyze the collected data. Despite these 
limitations, the collected data have been processed manually 
and present form has been prepared in order to make the 
study more informative, analytical and useful for the users.  
RESEARCH RESULTS AND FINDINGS 
The collected data of the square pharmaceutical limited 
has been analyzed from different perspective to know its 
role towards the economy of Bangladesh. 
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Table 1: Market Growth Trend 
Year National Market  
Growth Rate 
Company’s  
Growth Rate 
2013 23.80% 17.53% 
2014 22.30% 19.17% 
2015 11.91% 11.87% 
2016 8.12% 16.43% 
2017 11.36% 25.36% 
Source: IMS Report, 2017 
The growth trend shows in table 1 indicating positive 
outlook. The growth of the economy at 6.12% of 
Bangladesh during the fiscal year 2016-17 and its 
allevation to the lower-middle income group of nations 
from that of LDCs. The outlook of the table 1 of National 
Market Growth Rate and Company’s Growth Rate shows 
the contribution of square pharmaceutical limited to the 
economy of Bangladesh where table shows in 2014 
National Market Growth Rate is 11.36% but SPL made the 
growth of 25.36% such situation offers scope for further 
growth in investment for expansion in this sector and the 
upwards economic growth of the country.  
Table 2: Contribution to National Exchequer 
Fiscal  
Year 
Amount  
(BDT) 
% of Sales  
Revenue (Net) 
2015-2016 5,113,387,771 24.09 
2016-2017 6,314,740,042 24.45 
Source: Annual Report, 2016-2017 
The above table shows that the SPL contributed a huge 
amount with significant percentage of sales revenue to the 
National Exchequer other than any other respective 
companies in Bangladesh. And its historical contribution to 
the National Exchequer is upwards trends following. As well 
the contribution constitutes 24.45% of the sales revenue in 
2016-17 as against 24.09% in the previous year of 2015-2016. 
Table 3: Operating Financial Results 
Particulars 2016-2017  
(BDT) 
2015-2016  
(BDT) 
%  
Increase 
Gross Turnover 30,281,713,746 24,193,356,807 25.17% 
Net Turnover 26,212,862,068 20,910,773,826 25.36% 
Gross Profit 11,841,989,969 9,182,781,155 28.96% 
Net Profit (BT) 7,595,901,234 5,504,459,836 38.00% 
Provision for Taxation 1,679,877,193 1,329,682,520 26.34% 
Net Profit (AT) 5,743,623,832 4,031,811,286 42.46% 
Source: Annual Report, 2014-2015 
The table no 3 indicating the operating financial performance 
of square pharmaceutical limited during the consecutive two 
fiscal years where the net profit after tax has been increased 
at 42.46% than its previous year. Such showdown of increase 
of net profit is indicating the role of square pharmaceutical 
limited to the economy of the country and the public as well. 
The contribution to the government of square 
pharmaceutical limited can be easily understand by using 
the information of provision for taxation that is 26.34% more 
than the preceding years of 2017.    
Table 4: Financial Outcomes  
Particulars 2016-2017  2015-2016  %  
Increase 
Gross Margin (Net Turnover) 45.17% 43.91% 2.87% 
Net Margin (BT) 28.98% 26.32% 10.11% 
Net Margin (AT) 21.91% 19.28% 13.64% 
Earnings Per Share (EPS)  
(BDT) 
10.36 7.27 42.50% 
EPS on IPO 574.36 403.18 42.46% 
Consolidated Earnings Per  
Share (EPS) (BDT) 
10.80 8.92 21.08% 
Source: Annual Report, 2014-2015 
The earnings per share towards the common stock holders of 
the fiscal year 2016-2017 become BDT 10.36 that is 42.50% 
more than the previous year of 2015-2016 is indicated by the 
table 4. As well the consolidated earnings per share in the 
fiscal year become BDT 10.80 that is 21.08% more than the 
previous year. The entire information of the table 4 focusing 
about the contribution of square pharmaceutical limited 
towards the economy and people of Bangladesh. 
Figure 1: Value Added Statement 
 
Source: Annual Report, 2014-2015 
The above graph shows the value added statement during 
the two consecutive fiscal years of 2015-16 & 2016-17 where 
the contributing forces are shown as duties and taxes to govt. 
exchequer which have the increasing trends. The 
contribution towards the employees has also been increased, 
the stockholders are receiving more dividends and only the 
pyramids bar of 2016-2017 is showing the downwards 
direction  in case of retained earning that is another good sign 
for the economy and people of the country. 
Figure 2: Graphical Presentations of Historic Turnover 
and Its Growth 
 
Source: Annual Report, 2016-2017 
The turnover and its historic growth over the five years 
periods of square pharmaceutical limited is shown in the 
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figure no 2. The highest growth of 25.17% is seen in the 
current year with the turnover of BDT 30,282 millions and 
that growth is 8% more than the initial period of the study 
that is 2013-2014. This figure also indicating the amount of 
turnover of current is almost BDT 10,000 millions more 
than the initial period of the study.   
Figure 3: Graphical Presentations of Historic Net Profit 
(AT) and Its Growth 
 
Source: Annual Report, 2016-2017 
The figure no 3 that is presenting of historic net profit 
(After Tax) and its growth of square pharmaceutical 
limited focusing the contribution towards the economy 
and people of Bangladesh as the profit is almost 
distributed to the public of the country. More than five 
and half thousand millions BDT has been made as net 
profit with the growth rate of 42.5% in the FY 2016-
2017that is more than double figure than those of FY 2012-
2013. This picture is strongly showed about the role and 
contribution of square pharmaceutical limited. 
As a dominant and the biggest name in the 
pharmaceutical sector of Bangladesh square 
pharmaceutical is playing a vital role to the society of the 
country as the activities of CSR where corporate social 
responsibility (CSR) is the continuing commitment by 
business to behave ethically and contribute to economic 
development while improving the quality of life of the 
workforce and their families as well as of the local 
community and society at large.  
The first and significant corporate social responsibility is 
played by square pharmaceutical limited is determined and 
committed to safeguard public health of the country by 
providing quality product that is operating 24/7 free 
helpline termed as Supermom is a free telephone (+880 961 
2222 333) service and a full-fledged interactive Bengali 
website (www.supermombd.com) for mothers and their 
babies for the purpose healthy family. Square Toiletries 
Limited is doing their responsibility as the part of society by 
educating 1.5 million girls regarding adolescent health & 
hygiene, ensuring a healthy future for 3.3 millions babies and 
a healthy future for 1.6 millions girls. Through direct 
outbound phone call, SMS blast, product pack 
communication, Square Toiletries Ltd. attempted to make 
mothers aware about the importance of breast feeding and 
vaccination that is helping to ensure the future of 3.3 million 
babies and help eliminate polio from Bangladesh as well. 
Square is partnering one of the projects of CARE the 
organization of ‘JICA’, through this project it is ensured 
empowerment of rural women as they can earn money by 
purchasing its products at trade price & by selling those 
products to rural households at maximum retail price (MRP) 
and also ensure basic health & hygiene to the rural area by 
the sales women in explaining the necessity of using sanitary 
napkin and health soaps and making these products 
available at their doorsteps. It supplies customized 
government medicine as per the requirement of Bangladesh 
government. Moreover, in times of epidemics and disasters 
it is always beside the government with its expanded helping 
hands. It is also conducting transparent business operations 
based on market mechanism within the legal, ethical & social 
framework that enables the management to ensure highest 
degree of both financial and behavioral accountability. For 
the betterment of the employees, it follows the updated and 
latest labor policies and laws that encourage work 
environment for making non-discrimination & fair treatment 
policy both in the recruitment & selection process and 
performance management system. As the activity of 
corporate social responsibility Square pharmaceutical 
limited helps many NGO's in their effort to make available 
healthcare to the disadvantage population of the country. It 
sponsors programs to build awareness on the healthcare 
need. Square pharmaceutical limited is making its significant 
role in the education sector of the country that it is 
constructed both Kindergarten and high school to facilitate 
quality education to the children of the employees in the 
northern zone Pabna of the country that a 100% ‘not- for-
profit’ initiative where the students receive quality education 
at a very subsidized fee. Other than its own employees' 
children, it also provides this education facility for the 
children of local community. The company maintains a high 
standard of pollution free environment as per GMP 
Regulations or WHO standards or the government laws. 
Moreover, square pharmaceutical limited takes multiple 
initiatives through healthcare publications, seminars & 
clinical meetings like Continual Medical Education (CME) 
program building awareness about the health care of the 
poor people. It is also building the awareness program for the 
rights of physically-challenged people. Besides these square 
pharmaceutical limited arranges road safety campaign & 
road side shade and making donation to hospitals, medical 
colleges, local community & underprivileged people.  
CONCLUSION AND RECOMMENDATION 
The pharmaceutical industries in Bangladesh are gifted 
with unparalleled potential to grow in the days ahead as 
they enjoy a number of competitive advantages. The 
industry’s ability to comply with guidelines of quality 
assurance has put it on a solid base. Almost all companies 
are equipped with World Health Organization (WHO) 
Good Manufacturing Practice (GMP) standards.  
It has the ability to face competition from developing 
countries like India, China, Brazil and Turkey in its export 
markets due to strict quality compliance. As the leading 
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company in the pharmaceutical world of Bangladesh square 
pharmaceutical limited is playing a vital role to the economy 
of the country and it also contributing to the society as the 
CSR activities that is assessed and investigated in this paper. 
From the study the role of square pharmaceutical limited to 
the both domestic and international pharmaceutical sector is 
examined and seen. Though square pharmaceutical limited 
is contributing to the country from both economic and social 
perspective, but the research chalk out some 
recommendations those should be consider by the 
pharmaceutical companies, the respective authorities and 
the government of the country as well, such as: 
 The concerned company and the authority should be 
conscious about the laboratory because the laboratory 
facilities are still not up to date. To maintain the 
quality of the medicines drug control authority of 
Bangladesh should set up laboratories with modern 
testing equipment. 
 There should be taken care of the exporting procedure 
and facilities because the customs authority of 
Bangladesh has some strict rules and regulation in 
case of sending drug samples to importing countries. 
Because of these restrictions the pharmaceutical 
companies are losing international market as they 
can’t send sufficient amount of samples to the buyers. 
 The researcher thinks that the regulatory authorities 
of USA, EU, Australia, Japan and other highly 
regulated and semi regulated countries have strict 
regulation in registering pharmaceutical products. 
Regulatory markets have their own criteria like high-
tech manufacturing plant, standard manufacturing 
process, accurate quality control and highly skilled 
employees but most of the companies of Bangladesh 
are unable to meet these criteria. 
 The researchers also found that every year the 
medicine manufacturing companies recruit medical 
representatives but they can hardly affect the market 
as they lack proper training and professionalism. 
Because of having no sufficient incentives in 
comparison with their effort, the turnover rate of 
medical representatives is very high. Current political 
turbulence and bureaucratic obstacles are hampering 
the export of pharmaceutical products.  
 Besides those, the researcher recommend that there are 
some principles for the manufacture of medicines and 
APIs (Active Pharmaceutical Ingredients), these principles 
are known as Good Manufacturing Practice (GMP) or 
current Good Manufacturing Practice (cGMP) and it is 
also one of the requirements of regulatory markets. 
 The government should offer more incentives to those 
who invest in the API industries. If this is ensured, a 
growth rate of 80% can be expected in the coming years.  
 Moreover, the researcher pointed out that the drug 
manufacturers, on their part, should make efforts to 
drive out counterfeit drugs and medicines from the 
market. As well the government, on its part, should 
launch drives on a continuous basis against 
counterfeit and spurious drugs by strengthening the 
Drug Administration 
From this study the researcher come into the point that 
Square Pharmaceuticals Limited the pharmaceutical giant 
in the country, is a trusted name in the industry of 
manufacturing quality medicines for more than four 
decade with the growth of turnover came the increase in 
number of employees. The government should really be 
attentive to remove all the obstacles and solve all the 
problems to see pharmaceutical sector as a vital player in 
both domestic and international market. 
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